Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:43 pm Sale | 2026-03-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | PAULSON & CO. INC. | 1,392,188 6.100% | -315,334 (-18.47%) | Filing History |
| 2026-05-15 12:37 pm Purchase | 2026-03-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | JANUS HENDERSON GROUP PLC JHG | 2,018,647 8.800% | 433,804 (+27.37%) | Filing History |
| 2026-03-27 10:34 am Sale | 2026-03-13 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | VANGUARD GROUP INC | 0 0.000% | -1,574,742 (Position Closed) | Filing History |
| 2026-02-17 5:19 pm Sale | 2025-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | PAULSON & CO. INC. | 1,707,522 7.500% | -334,478 (-16.38%) | Filing History |
| 2026-02-17 4:34 pm Sale | 2025-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | JANUS HENDERSON GROUP PLC JHG | 1,584,843 7.000% | -257,847 (-13.99%) | Filing History |
| 2025-12-12 6:10 pm Unchanged | 2025-12-10 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | Taub Rebecca | 1,814,831 7.800% | 0 (Unchanged) | Filing History |
| 2025-12-12 6:10 pm Unchanged | 2025-12-10 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | FRIEDMAN PAUL A | 1,814,831 7.800% | 0 (Unchanged) | Filing History |
| 2025-11-14 12:06 pm Sale | 2025-09-30 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | JANUS HENDERSON GROUP PLC JHG | 1,842,690 8.300% | -349,063 (-15.93%) | Filing History |
| 2025-08-14 11:24 am Sale | 2025-06-30 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | JANUS HENDERSON GROUP PLC JHG | 2,191,753 9.900% | -14,231 (-0.65%) | Filing History |
| 2025-05-14 12:15 pm Sale | 2025-03-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | JANUS HENDERSON GROUP PLC JHG | 2,205,984 10.000% | -2,410 (-0.11%) | Filing History |
| 2025-02-14 12:10 pm Sale | 2024-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | JANUS HENDERSON GROUP PLC JHG | 2,208,394 10.100% | -269,766 (-10.89%) | Filing History |
| 2024-11-14 5:18 pm Purchase | 2024-09-30 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | PAULSON & CO. INC. | 2,042,000 9.400% | 936,259 (+84.67%) | Filing History |
| 2024-11-14 4:00 pm Sale | 2024-09-30 | 13G | 89BIO INC ETNB | JANUS HENDERSON GROUP PLC JHG | 2,478,160 11.400% | -12,680,058 (-83.65%) | Filing History |
| 2024-11-14 06:30 am Purchase | 2024-09-30 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | RTW Investments, LP | 1,993,687 9.200% | 1,993,687 (New Position) | Filing History |
| 2024-03-25 4:28 pm Purchase | 2024-03-21 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 2,070,544 9.990% | 82,842 (+4.17%) | Filing History |
| 2024-02-14 4:47 pm Purchase | 2023-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | PAULSON & CO. INC. | 1,105,741 5.600% | 105,741 (+10.57%) | Filing History |
| 2024-02-14 2:50 pm Sale | 2023-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | Armistice Capital, LLC | 50,000 0.250% | -158,000 (-75.96%) | Filing History |
| 2024-02-14 09:21 am Purchase | 2023-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | Avoro Capital Advisors LLC | 2,288,888 9.900% | 628,888 (+37.88%) | Filing History |
| 2024-02-13 5:55 pm Sale | 2023-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | JANUS HENDERSON GROUP PLC JHG | 2,902,050 14.700% | -140,611 (-4.62%) | Filing History |
| 2024-02-13 5:08 pm Purchase | 2023-12-29 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | VANGUARD GROUP INC | 1,574,742 7.980% | 308,367 (+24.35%) | Filing History |